Medindia LOGIN REGISTER
Medindia
Advertisement

Genomma Lab Internacional Reports Fourth Quarter & Full Year 2018 Results

Wednesday, February 27, 2019 Clinical Trials News
Advertisement

Q4-2018

 % Sales

Q4-2017

% Sales

Var. %

Net Sales

3,136.4

100.0%

2,885.2

100.0%

+8.7%

Gross Profit

2,012.9

64.2%

1,798.0

62.3%

+11.9%

Operating Income

550.6

17.6%

595.9

20.7%

(7.6)%

EBITDA(2)

579.3

18.5%

613.2

21.3%

(5.5)%

Net Income(3) 

327.0

10.4%

338.6

11.7%

(3.4)%

(2) EBITDA is defined as operating income before depreciation and amortization.

(3) Net Income of Majority Shareholders for 2017.

Sponsored Post and Backlink Submission


Latest Press Release on Clinical Trials News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close